Amylyx Pharmaceuticals Won Regulatory Approval for Its Controversial Treatment for ... - Latest Tweet by Bloomberg

Amylyx Pharmaceuticals won regulatory approval for its controversial treatment for amyotrophic lateral sclerosis, making it the third major medicine authorized in the US to slow the disease https://t.co/Z8Zo3VQr9L— Bloomberg (@business) September 29, 2022

(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)